The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Recordati Rare Diseases Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
9 result(s) found, displaying 1 to 9
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISTURISA osilodrostat (as phosphate) 5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISTURISA osilodrostat (as phosphate) 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISTURISA osilodrostat (as phosphate) 1 mg film-coated tablet blister pack.
-
CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial (351010)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial. -
Australian Public Assessment Report (AusPAR)AusPAR for Isturisa (osilodrostat as phosphate) for the treatment of endogenous Cushing’s syndrome in adults.
-
-
Prescription medicine registrationActive ingredients: osilodrostat phosphate.
-
Prescription medicine registrationActive ingredients: mercaptamine (cysteamine).
-
Prescription medicine registrationActive ingredients: mercaptamine (cysteamine).